Patent · US Active

Methods for treating cancer with RORγ inhibitors

US10959984B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Hongwu Chen · Scarborough, CA
June X. Zou · Richmond, US
Junjian Wang · Zhengzhou, CN

Key dates

Filing date	Sep 11, 2017
Grant date	Mar 30, 2021
Priority date	—
Expiry date	Sep 11, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compositions, methods, and kits comprising one or more RORγ inhibitors, alone or in combination with one or more anticancer drugs, such as an anti-androgen drug, that are useful for treating cancer, e.g., prostate cancer, such as castration-resistant prostate cancer (CRPC), and numerous other types of cancer including lung cancer, breast cancer, liver cancer, ovarian cancer, endometrial cancer, bladder cancer, colon cancer, lymphoma, and glioma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.